Over the last 12 months, one Pacific Health Care Organization Inc insiders bought shares in open-market trades, about $90,000 in total, and none of them sold.
KUBOTA TOM (CEO) made the biggest buy, worth around $65,000. Notably, at least one C-suite executive was among the buyers.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | KUBOTA TOM | CEO | Buy | 24,742 | $1.00 | $25K | SEC |
| Jun 2, 2026 | KUBOTA TOM | CEO | Buy | 65,258 | $1.00 | $65K | SEC |
| Jun 28, 2024 | KUBOTA TOM | CEO | Buy | 2,499 | $0.99 | $2K | SEC |
| Jun 28, 2024 | KUBOTA TOM | CEO | Buy | 10,000 | $0.98 | $10K | SEC |
| Jun 28, 2024 | KUBOTA TOM | CEO | Buy | 6,000 | $0.94 | $6K | SEC |
| Jun 28, 2024 | KUBOTA TOM | CEO | Buy | 2,500 | $0.96 | $2K | SEC |
| Jun 24, 2024 | KUBOTA TOM | CEO | Buy | 4,500 | $0.87 | $4K | SEC |
| Jun 24, 2024 | KUBOTA TOM | CEO | Buy | 270 | $0.75 | $202 | SEC |
| Jun 24, 2024 | KUBOTA TOM | CEO | Buy | 1,500 | $0.95 | $1K | SEC |
| Jun 7, 2024 | KUBOTA TOM | CEO | Buy | 140 | $0.79 | $111 | SEC |
| Jun 7, 2024 | KUBOTA TOM | CEO | Buy | 15,860 | $0.83 | $13K | SEC |
| May 31, 2024 | KUBOTA TOM | CEO | Buy | 6,084 | $0.75 | $5K | SEC |
| May 29, 2024 | KUBOTA TOM | CEO | Buy | 4,800 | $0.74 | $4K | SEC |
| May 29, 2024 | KUBOTA TOM | CEO | Buy | 4,000 | $0.74 | $3K | SEC |
| May 23, 2024 | KUBOTA TOM | CEO | Buy | 100 | $0.71 | $71 | SEC |
In the last 12 months Pacific Health Care Organization Inc insiders made open-market purchases worth about $90,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PFHO was filed on 2026-06-04.
No congressional trades in PFHO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).